Sobi medicines in United Kingdom 

These are our medicines available in the United Kingdom please click on the name for the SPC and PIL information:

• Alprolix^® (eftrenonacog alfa)
• ▼ Altuvoct^®(efanescotocog alfa)
• Aspaveli^®(pegcetacoplan)
• Doptelet^®(avatrombopag)
• Elocta^® (efmoroctocog alfa)
• Kineret^® (anakinra)
• Orfadin^® (nitisinone)
• ▼Tryngolza^®(Olezarsen)
• ▼Zynlonta^®(loncastuximab tesirine)

Distributed Medicines

• ▼Waylivra^®(volanesorsen)

▼ This treatment is subject to additional monitoring

Patient safety is a priority for Sobi. We are committed to collect, analyse and react upon any new information about the benefits and risks of our treatments. If you have information about a side effect or adverse reaction associated with any of our products, please use our online reporting form: Report a side effect

If you are unable to submit a side effect electronically, please use the local safety contact details available on the reporting page linked above.

Please also report any suspected adverse reactions directly to the Medicines and Healthcare Regulatory Authority via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store

For Product Complaints, please contact [email protected]

For Medical Information enquiries, please contact +44 (0)800 111 4754 or email [email protected]